Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Kaune

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Scientific Reports|June 20, 2020
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targetingSergey A Dyshlovoy, Ekaterina K Kudryashova, Moritz Kaune, et al.
Marine Drugs|December 4, 2020
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer CellsSergey A Dyshlovoy, Moritz Kaune, Jessica Hauschild, et al.
Marine Drugs|May 15, 2020
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate CancerSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
International Journal of Molecular Sciences|December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate CancerGunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
Cancers|November 2, 2019
Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-NaphthoquinonesSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
Marine Drugs|March 24, 2022
Study of Structure-Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer AgentsMaxim E Zhidkov, Moritz Kaune, Alexey V Kantemirov, et al.
Molecular Pharmaceutics|September 21, 2023
Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro ModelsSergey A Dyshlovoy, Jessica Hauschild, Simone Venz, et al.
Molecular Cancer Therapeutics|April 29, 2025
6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancerTobias Busenbender, Dmitry N Pelageev, Jessica Hauschild, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Scientific Reports|June 20, 2020
Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targetingSergey A Dyshlovoy, Ekaterina K Kudryashova, Moritz Kaune, et al.
Marine Drugs|December 4, 2020
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer CellsSergey A Dyshlovoy, Moritz Kaune, Jessica Hauschild, et al.
Marine Drugs|May 15, 2020
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate CancerSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
International Journal of Molecular Sciences|December 11, 2022
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate CancerGunhild von Amsberg, Mirjam Zilles, Wael Mansour, et al.
Cancers|November 2, 2019
Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-NaphthoquinonesSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
Marine Drugs|March 24, 2022
Study of Structure-Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer AgentsMaxim E Zhidkov, Moritz Kaune, Alexey V Kantemirov, et al.
Molecular Pharmaceutics|September 21, 2023
Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro ModelsSergey A Dyshlovoy, Jessica Hauschild, Simone Venz, et al.
Molecular Cancer Therapeutics|April 29, 2025
6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancerTobias Busenbender, Dmitry N Pelageev, Jessica Hauschild, et al.
Pageof 2